Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
13F holders, Q4 2025
Institutional positions in Medicus Pharma Ltd. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +1 vs. Q3 2025
- Shares held
- 3.94M
- +1.82M (+85.9%) vs. Q3 2025
- Total value
- $6.03M
- +$1.12M (+22.9%) vs. Q3 2025
- New holders
- 7
- 7 more added
- Sold out
- 6
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.18M |
| Q1 2026 | 21 | $301.6K |
| Q4 2025 | 21 | $6.03M |
| Q3 2025 | 20 | $4.91M |
| Q2 2025 | 21 | $6.60M |
| Q1 2025 | 7 | $11.4M |
| Q4 2024 | 3 | $3.74M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Medicus Pharma Ltd.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,810,960 | $2.77M | 0.07% | +1,810,960 | New |
| Interchange Capital Partners, LLC | 1,586,871 | $2.43M | 0.45% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 175,495 | $268.5K | 0.00% | +23,995+15.8% | Added |
| Jane Street Group, LLC | 60,337 | $92.3K | 0.00% | +60,337 | New |
| Bryn Mawr Trust Co | 51,244 | $78.4K | 0.00% | +25,622+100.0% | Added |
| Susquehanna International Group, LLP | 40,162 | $61.4K | 0.00% | +40,162 | New |
| May Hill Capital, LLC | 35,622 | $54.5K | 0.01% | +17,811+100.0% | Added |
| BlackRock, Inc. | 34,317 | $52.5K | 0.00% | +18,101+111.6% | Added |
| Commonwealth Equity Services, LLC | 28,493 | $43.6K | 0.00% | +17,611+161.8% | Added |
| HRT Financial LP | 27,529 | $42.0K | 0.00% | +27,529 | New |
| Brave Asset Management Inc | 20,000 | $30.6K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 18,306 | $28.0K | 0.00% | +12,338+206.7% | Added |
| Smithfield Trust Co | 13,883 | $21.0K | 0.00% | +13,883 | New |
| UBS Group AG | 13,231 | $20.2K | 0.00% | +6,274+90.2% | Added |
| Two Sigma Investments, LP | 12,319 | $18.8K | 0.00% | +12,319 | New |
| Advisor Group Holdings, Inc. | 8,500 | $13.0K | 0.00% | −5,500−39.3% | Reduced |
| Larson Financial Group LLC | 1,000 | $1.53K | 0.00% | 00.0% | Unchanged |
| Hazlett, Burt & Watson, Inc. | 425 | $1.00K | 0.00% | +425 | New |
| Jones Financial Companies LLLP | 400 | $612 | 0.00% | 00.0% | Unchanged |
| DAGCO, Inc. | 349 | $534 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $115 | 0.00% | 00.0% | Unchanged |
| Yorkville Advisors Global, LP | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −18,751−100.0% | Sold out |
| Base Wealth Management LLC | 0 | $0 | 0.00% | −11,543−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −222−100.0% | Sold out |